Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05687188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

StatusActive, Not Recruiting
PhaseNot specified
Started2023-02-22
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 19 months later Dec 2026 → Aug 2028
See other at-risk trials from H. Lee Moffitt Cancer Center and Research Institute

Amendment history

2026-09-26
Enrollment closed, study ongoing
Final enrollment: 185 participants (planned 125)
Primary completion pushed: 2026-12 → 2028-08
Completion pushed: 2026-12 → 2028-08
2026-05-21
Study Status, Contacts/Locations v11
Study sitesdetails revised at 1 of 2 sites
2026-02-05
Study Status, Contacts/Locations v10
Study sitesdetails revised at 1 of 2 sites
2025-11-12
5 amendments v5-v9
5 re-verifications since 2024-09-30, no change to tracked fields
2024-05-16
Study Status, Contacts/Locations v4
Study sitescontacts updated at 1 of 2 sites
Show 3 earlier versions
2024-05-08
Active, Not Recruiting→Recruiting Study Status, Study Design, Contacts/Locations v3
Trial statusActive, Not Recruiting→Recruiting
Primary completion date2025-12→2026-12
Completion date2025-12→2026-12
Enrollment target91→125
Study sitesdetails revised at 2 of 2 sites
2023-11-02
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v2
Trial statusRecruiting→Active, Not Recruiting
Enrollment targetestimated 90→confirmed 91
Study sitesdetails revised at 2 of 2 sites
2023-06-16
Study Status v1
Start date2022-12-12→2023-02-22
2023-01-06
Original filing
This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
Trial Details
NCT Number NCT05687188
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Collaborators: United States Department of Defense
Conditions Pancreatic Cancer
Enrollment 185 participants
Start Date 2023-02-22
Primary Completion 2028-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-09-25